Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of ENG-E2 vaginal ring versus levonorgestrel + ethinylestradiol oral contraceptive for contraception
2014-002208-26Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in contraception comparing MK-8342B vaginal ring with Microgynon 21 oral contraceptive (2 arms). Primary endpoint: Primary efficacy endpoint. Started Aug 2015; status: completed.
02
Drugs
ENG-E2ethinylestradiol + levonorgestrel
03
Conditions
contraception
Beyond the preview
Go deeper on 2014-002208-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002208-26.